PT1144006E - Pa14: anticorpo contra o ccr5 - Google Patents
Pa14: anticorpo contra o ccr5 Download PDFInfo
- Publication number
- PT1144006E PT1144006E PT99966466T PT99966466T PT1144006E PT 1144006 E PT1144006 E PT 1144006E PT 99966466 T PT99966466 T PT 99966466T PT 99966466 T PT99966466 T PT 99966466T PT 1144006 E PT1144006 E PT 1144006E
- Authority
- PT
- Portugal
- Prior art keywords
- ccr5
- antibody
- hiv
- quot
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21279398A | 1998-12-16 | 1998-12-16 | |
| US11253298P | 1998-12-16 | 1998-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1144006E true PT1144006E (pt) | 2007-12-11 |
Family
ID=26810060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99966466T PT1144006E (pt) | 1998-12-16 | 1999-12-16 | Pa14: anticorpo contra o ccr5 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP1144006B1 (https=) |
| JP (1) | JP2002538771A (https=) |
| AT (1) | ATE375802T1 (https=) |
| AU (3) | AU773175B2 (https=) |
| CA (1) | CA2355607A1 (https=) |
| CY (1) | CY1107858T1 (https=) |
| DE (1) | DE69937369T2 (https=) |
| DK (1) | DK1144006T3 (https=) |
| ES (1) | ES2296416T3 (https=) |
| HK (1) | HK1041207B (https=) |
| MX (1) | MXPA01006097A (https=) |
| PT (1) | PT1144006E (https=) |
| WO (1) | WO2000035409A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0847452B1 (en) | 1995-06-07 | 2009-04-01 | Progenics Pharmaceuticals, Inc. | Monoclonal antibody for inhibiting hiv-1 envelope glycoprotein mediated membrane fusion |
| US7118859B2 (en) | 1996-01-17 | 2006-10-10 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
| AU2265701A (en) * | 1999-12-16 | 2001-06-25 | Tanox, Inc. | Anti-hiv-1 conjugates for treatment of hiv disease |
| US7138119B2 (en) | 2000-09-15 | 2006-11-21 | Progenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
| US7060273B2 (en) | 2001-04-06 | 2006-06-13 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
| US20020146415A1 (en) * | 2001-04-06 | 2002-10-10 | Olson William C. | Methods for inhibiting HIV-1 infection |
| US20060078537A1 (en) * | 2001-12-21 | 2006-04-13 | Matthias Mack | Mono-and dual chemokine/cytokine constructs |
| DE60324664D1 (de) * | 2002-02-22 | 2008-12-24 | Pdl Biopharma Inc | Anti-ccr5 antikörper |
| US7122185B2 (en) | 2002-02-22 | 2006-10-17 | Progenics Pharmaceuticals, Inc. | Anti-CCR5 antibody |
| TW200720289A (en) | 2005-04-01 | 2007-06-01 | Hoffmann La Roche | Antibodies against CCR5 and uses thereof |
| JP2009525301A (ja) * | 2006-01-30 | 2009-07-09 | エフ．ホフマン−ラ ロシュ アーゲー | Ｈｉｖを処置するための相乗的組成物 |
| TW200817438A (en) | 2006-08-17 | 2008-04-16 | Hoffmann La Roche | A conjugate of an antibody against CCR5 and an antifusogenic peptide |
| AU2007286451A1 (en) | 2006-08-17 | 2008-02-21 | F. Hoffmann-La Roche Ag | A conjugate of an antibody against CCR5 and an antifusogenic peptide |
| KR20090052358A (ko) | 2006-09-29 | 2009-05-25 | 에프. 호프만-라 로슈 아게 | Ｃｃｒ5 에 대한 항체 및 이의 용도 |
| CL2008000707A1 (es) | 2007-03-13 | 2008-09-22 | Hoffmann La Roche | Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion. |
| EP2741777B1 (en) | 2011-08-12 | 2017-01-18 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
| US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3375697A (en) * | 1996-05-28 | 1998-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cc chemokine receptor 5, antibodies thereto, transgenic animals |
| AU735460B2 (en) * | 1996-06-14 | 2001-07-12 | Aaron Diamond Aids Research Center, The | Uses of a chemokine receptor for inhibiting HIV-1 infection |
| US6528625B1 (en) * | 1996-10-28 | 2003-03-04 | Millennium Pharmaceuticals, Inc. | Anti-CCR5 antibodies and kits comprising same |
-
1999
- 1999-12-16 ES ES99966466T patent/ES2296416T3/es not_active Expired - Lifetime
- 1999-12-16 EP EP99966466A patent/EP1144006B1/en not_active Expired - Lifetime
- 1999-12-16 WO PCT/US1999/030345 patent/WO2000035409A2/en not_active Ceased
- 1999-12-16 PT PT99966466T patent/PT1144006E/pt unknown
- 1999-12-16 AU AU21996/00A patent/AU773175B2/en not_active Ceased
- 1999-12-16 HK HK02102467.8A patent/HK1041207B/en not_active IP Right Cessation
- 1999-12-16 AT AT99966466T patent/ATE375802T1/de not_active IP Right Cessation
- 1999-12-16 DK DK99966466T patent/DK1144006T3/da active
- 1999-12-16 MX MXPA01006097A patent/MXPA01006097A/es not_active IP Right Cessation
- 1999-12-16 EP EP08173136A patent/EP2088158A3/en not_active Withdrawn
- 1999-12-16 CA CA002355607A patent/CA2355607A1/en not_active Abandoned
- 1999-12-16 DE DE69937369T patent/DE69937369T2/de not_active Expired - Lifetime
- 1999-12-16 JP JP2000587730A patent/JP2002538771A/ja not_active Ceased
-
2004
- 2004-08-20 AU AU2004205164A patent/AU2004205164A1/en not_active Abandoned
- 2004-08-20 AU AU2004205165A patent/AU2004205165A1/en not_active Abandoned
-
2008
- 2008-01-17 CY CY20081100062T patent/CY1107858T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004205165A1 (en) | 2004-09-16 |
| EP2088158A2 (en) | 2009-08-12 |
| CA2355607A1 (en) | 2000-06-22 |
| AU2004205164A1 (en) | 2004-09-16 |
| JP2002538771A (ja) | 2002-11-19 |
| EP1144006A4 (en) | 2004-11-24 |
| DE69937369T2 (de) | 2008-07-24 |
| AU2199600A (en) | 2000-07-03 |
| HK1041207B (en) | 2007-12-28 |
| EP1144006A2 (en) | 2001-10-17 |
| ATE375802T1 (de) | 2007-11-15 |
| DK1144006T3 (da) | 2007-11-26 |
| DE69937369D1 (de) | 2007-11-29 |
| HK1041207A1 (en) | 2002-07-05 |
| WO2000035409A3 (en) | 2000-09-14 |
| AU773175B2 (en) | 2004-05-20 |
| ES2296416T3 (es) | 2008-04-16 |
| CY1107858T1 (el) | 2013-06-19 |
| EP1144006B1 (en) | 2007-10-17 |
| MXPA01006097A (es) | 2002-04-15 |
| WO2000035409A2 (en) | 2000-06-22 |
| EP2088158A3 (en) | 2010-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7060273B2 (en) | Methods for inhibiting HIV-1 infection | |
| US7666419B2 (en) | Anti-CCR5 antibody | |
| US20070231327A1 (en) | Anti-CCR5 antibodies | |
| US20020146415A1 (en) | Methods for inhibiting HIV-1 infection | |
| PT1144006E (pt) | Pa14: anticorpo contra o ccr5 | |
| RU2322454C2 (ru) | Антитело против ccr5 | |
| US20080015348A1 (en) | Nucleic acids encoding polypeptides of anti-CCR5 antibodies | |
| AU2007254697B2 (en) | Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto-I | |
| EP1900376A2 (en) | Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto | |
| HK1117065A (en) | Synergistic inhibition of hiv-1 fusion and attachment, compsitions and antobodies thereto | |
| HK1133020A (en) | Monoclonal antibody against the ccr5 chemokine receptor | |
| HK1072272B (en) | Anti-ccr5 antibody | |
| HK1131343A (en) | Anti-ccr5 antibody |